Hypomethylating therapy mitigates acute allograft rejection in a murine lung transplant model.

Frontiers in transplantation Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI:10.3389/frtra.2025.1612523
Kristine M Yarnoff, William N Daccarett-Bojanini, Andres F Villabona-Rueda, Manuel Sollmann, Franco R D'Alessio, Jeffrey M Dodd-O
{"title":"Hypomethylating therapy mitigates acute allograft rejection in a murine lung transplant model.","authors":"Kristine M Yarnoff, William N Daccarett-Bojanini, Andres F Villabona-Rueda, Manuel Sollmann, Franco R D'Alessio, Jeffrey M Dodd-O","doi":"10.3389/frtra.2025.1612523","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Acute cellular rejection of transplanted lung allografts involves activated cytotoxic T cells and reduced Regulatory T (Treg) cell function. Calcineurin inhibitors, the cornerstone of immunosuppressive regimens, suppress T cell cytotoxicity but inhibit Treg proliferation. The DNA hypomethylating agent decitabine (DAC) can abrogate T cell cytotoxicity while stimulating Treg proliferation.</p><p><strong>Methods: </strong>We sought to determine the effects of DAC treatment in a murine MHC-mismatched orthotopic lung transplant model.</p><p><strong>Results: </strong>Rescue treatment with DAC maintains lung allograft gross and histologic integrity with a reduction in cytotoxic T cell responses. CD4+FoxP3+ T cell depletion in Foxp3DTR mice exacerbated rejection lung injury compared to CD4+FoxP3+ T cell sufficient mice and failed to abolish the protective effect of DAC in this model. The protective effect of DAC was associated with a reduction in cytokine production from host T-cells.</p><p><strong>Discussion: </strong>Decitabine could offer a new line of treatment for acute lung allograft rejection, in part via its effects on Tregs.</p>","PeriodicalId":519976,"journal":{"name":"Frontiers in transplantation","volume":"4 ","pages":"1612523"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12230056/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/frtra.2025.1612523","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Acute cellular rejection of transplanted lung allografts involves activated cytotoxic T cells and reduced Regulatory T (Treg) cell function. Calcineurin inhibitors, the cornerstone of immunosuppressive regimens, suppress T cell cytotoxicity but inhibit Treg proliferation. The DNA hypomethylating agent decitabine (DAC) can abrogate T cell cytotoxicity while stimulating Treg proliferation.

Methods: We sought to determine the effects of DAC treatment in a murine MHC-mismatched orthotopic lung transplant model.

Results: Rescue treatment with DAC maintains lung allograft gross and histologic integrity with a reduction in cytotoxic T cell responses. CD4+FoxP3+ T cell depletion in Foxp3DTR mice exacerbated rejection lung injury compared to CD4+FoxP3+ T cell sufficient mice and failed to abolish the protective effect of DAC in this model. The protective effect of DAC was associated with a reduction in cytokine production from host T-cells.

Discussion: Decitabine could offer a new line of treatment for acute lung allograft rejection, in part via its effects on Tregs.

在小鼠肺移植模型中,低甲基化治疗可减轻急性同种异体移植排斥反应。
肺同种异体移植物移植的急性细胞排斥反应涉及细胞毒性T细胞活化和调节性T (Treg)细胞功能降低。钙调磷酸酶抑制剂,免疫抑制方案的基石,抑制T细胞的细胞毒性,但抑制Treg增殖。脱氧核糖核酸低甲基化剂地西他滨(DAC)可以消除T细胞的细胞毒性,同时刺激Treg增殖。方法:我们试图确定DAC治疗对小鼠mhc错配原位肺移植模型的影响。结果:DAC的抢救治疗维持了同种异体肺移植的大体和组织学完整性,减少了细胞毒性T细胞反应。与CD4+FoxP3+ T细胞充足小鼠相比,Foxp3DTR小鼠CD4+FoxP3+ T细胞缺失加重了排异肺损伤,并不能消除DAC在该模型中的保护作用。DAC的保护作用与宿主t细胞细胞因子产生的减少有关。讨论:地西他滨可能通过其对treg的作用,为急性同种异体肺移植排斥提供一条新的治疗途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信